$ATOM
Atomera Inc Stock $atom

$atom Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000168316824005141 Filed on July 30, 2024

Income Statement

Concept	2024 Q3	2024 Q2
Revenue	$22.00K	$72.00K
YoY Change
Cost Of Revenue	$3.000K	$74.00K
YoY Change
Gross Profit	$19.00K	-$2.000K
YoY Change
Gross Profit Margin	86.36%	-2.78%
Selling, General & Admin	$2.060M	$2.039M
YoY Change	0.59%	-5.95%
% of Gross Profit	10842.11%
Research & Development	$2.759M	$2.589M
YoY Change	-16.52%	-18.89%
% of Gross Profit	14521.05%
Depreciation & Amortization	$273.0K	$294.0K
YoY Change	-11.94%	-5.16%
% of Gross Profit	1436.84%
Operating Expenses	$4.819M	$4.628M
YoY Change	-9.98%	-13.66%
Operating Profit	-$4.800M	-$4.630M
YoY Change	-10.33%	-13.62%
Interest Expense	$146.0K	$150.0K
YoY Change	210.64%	48.51%
% of Operating Profit
Other Income/Expense, Net	$205.0K	$269.0K
YoY Change	-34.71%	151.4%
Pretax Income	-$4.595M	-$4.361M
YoY Change	-8.83%	-15.35%
Income Tax
% Of Pretax Income
Net Earnings	-$4.595M	-$4.361M
YoY Change	-8.81%	-15.35%
Net Earnings / Revenue	-20886.36%	-6056.94%
Basic Earnings Per Share	-$0.17	-$0.16
Diluted Earnings Per Share	-$0.17	-$0.16
COMMON SHARES
Basic Shares Outstanding	27.80M shares	26.89M shares
Diluted Shares Outstanding	27.41M shares	26.47M shares

Balance Sheet

Concept	2024 Q3	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$17.34M	$18.29M
YoY Change	-14.95%	-23.27%
Cash & Equivalents	$13.76M	$14.48M
Short-Term Investments	$3.585M	$3.804M
Other Short-Term Assets	$388.0K	$578.0K
YoY Change	-0.51%	-11.08%
Inventory
Prepaid Expenses
Receivables	$6.000K	$6.000K
Other Receivables	$56.00K	$74.00K
Total Short-Term Assets	$17.79M	$18.95M
YoY Change	-14.61%	-22.78%
LONG-TERM ASSETS
Property, Plant & Equipment	$63.00K	$75.00K
YoY Change	-51.16%	-98.28%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$105.0K	$105.0K
YoY Change	-4.55%	0.0%
Total Long-Term Assets	$2.348M	$2.922M
YoY Change	-41.18%	-34.4%
TOTAL ASSETS
Total Short-Term Assets	$17.79M	$18.95M
Total Long-Term Assets	$2.348M	$2.922M
Total Assets	$20.14M	$21.87M
YoY Change	-18.89%	-24.56%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$786.0K	$646.0K
YoY Change	70.13%	14.95%
Accrued Expenses	$172.0K	$249.0K
YoY Change	-25.22%	-76.4%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.194M	$1.386M
YoY Change	-8.15%	2.14%
Total Short-Term Liabilities	$3.386M	$3.144M
YoY Change	14.74%	5.72%
LONG-TERM LIABILITIES
Long-Term Debt	$781.0K	$1.108M
YoY Change	-62.27%	-53.37%
Other Long-Term Liabilities	$80.00K	$137.0K
YoY Change	-77.14%	-65.75%
Total Long-Term Liabilities	$861.0K	$1.245M
YoY Change	-64.42%	-55.15%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.386M	$3.144M
Total Long-Term Liabilities	$861.0K	$1.245M
Total Liabilities	$4.247M	$4.389M
YoY Change	-20.84%	-23.67%
SHAREHOLDERS EQUITY
Retained Earnings	-$216.9M	-$212.3M
YoY Change	9.25%	9.72%
Common Stock	$232.8M	$229.8M
YoY Change	6.78%	6.02%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$15.89M	$17.48M
YoY Change
Total Liabilities & Shareholders Equity	$20.14M	$21.87M
YoY Change	-18.89%	-24.56%

Cashflow Statement

Concept	2024 Q3	2024 Q2
OPERATING ACTIVITIES
Net Income	-$4.595M	-$4.361M
YoY Change	-8.81%	-15.35%
Depreciation, Depletion And Amortization	$273.0K	$294.0K
YoY Change	-11.94%	-5.16%
Cash From Operating Activities	-$2.895M	-$3.164M
YoY Change	-16.81%	-19.65%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$6.000K
YoY Change	-100.0%	100.0%
Acquisitions
YoY Change
Other Investing Activities	$272.0K	$689.0K
YoY Change	-91.63%	-111.66%
Cash From Investing Activities	$272.0K	$683.0K
YoY Change	-91.6%	-111.55%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.896M	2.159M
YoY Change	-6420.0%	-79.7%
NET CHANGE
Cash From Operating Activities	-2.895M	-3.164M
Cash From Investing Activities	272.0K	683.0K
Cash From Financing Activities	1.896M	2.159M
Net Change In Cash	-727.0K	-322.0K
YoY Change	169.26%	-140.97%
FREE CASH FLOW
Cash From Operating Activities	-$2.895M	-$3.164M
Capital Expenditures	$0.00	$6.000K
Free Cash Flow	-$2.895M	-$3.170M
YoY Change	-17.05%	-19.56%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q2	ATOM	Unbilled Contracts Receivable Current UnbilledContractsReceivableCurrent	0	usd
CY2023Q4	ATOM	Unbilled Contracts Receivable Current UnbilledContractsReceivableCurrent	550000	usd
CY2024Q2	ATOM	Longterm Prepaid Maintenance And Supplies LongtermPrepaidMaintenanceAndSupplies	91000	usd
	ATOM	Unrealized Gain Loss On Cash Equivalents UnrealizedGainLossOnCashEquivalents		usd
CY2024Q2	ATOM	Unbilled Contracts Receivable Current UnbilledContractsReceivableCurrent	0	usd
CY2023Q4	ATOM	Unbilled Contracts Receivable Current UnbilledContractsReceivableCurrent	550000	usd
CY2024Q2	ATOM	Longterm Prepaid Maintenance And Supplies LongtermPrepaidMaintenanceAndSupplies	91000	usd
CY2023Q4	ATOM	Longterm Prepaid Maintenance And Supplies LongtermPrepaidMaintenanceAndSupplies	91000	usd
CY2023Q4	ATOM	Longterm Prepaid Maintenance And Supplies LongtermPrepaidMaintenanceAndSupplies	91000	usd
CY2023Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	14000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3517000	usd
CY2024Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	207000	usd
CY2023Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	393000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	557000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	782000	usd
CY2024Q2	us-gaap	Operating Expenses OperatingExpenses	4628000	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	5360000	usd
	us-gaap	Operating Expenses OperatingExpenses	9647000	usd
	us-gaap	Operating Expenses OperatingExpenses	10527000	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-4630000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-5360000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-9664000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-10527000	usd
CY2024Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	185000	usd
CY2023Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	152000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	351000	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	74000	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	104000	usd
CY2024Q2	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	72000	usd
CY2023Q2	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	0	usd
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	72000	usd
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	0	usd
CY2024Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	269000	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	208000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	481000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	356000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-4361000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-5152000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-9183000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-10171000	usd
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.16
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.21
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	20314000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	927000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	39000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	274000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-5019000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-2000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	16533000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1030000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	39000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	10789000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-5152000	usd
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.42
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24171000	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	26467000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	26253000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24171000	shares
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-4361000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-5152000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-9183000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-10171000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-6000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	0	usd
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-7000	usd
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-2000	usd
CY2024Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4367000	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-5152000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-9190000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-10173000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1024000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	86000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	987000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2442000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	10000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-4361000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-6000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	17479000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	20314000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	927000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	39000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	274000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-5019000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	16533000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1030000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	39000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	10789000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-5152000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	23239000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-9183000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-10171000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	30000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	23239000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-9183000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-10171000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	30000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	40000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	116000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	102000	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	562000	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	581000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2011000	usd
	ATOM	Unrealized Gain Loss On Cash Equivalents UnrealizedGainLossOnCashEquivalents	1000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	-87000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	-89000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	6000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-0	usd
	ATOM	Increase Decrease In Unbilled Contracts Receivable IncreaseDecreaseInUnbilledContractsReceivable	-550000	usd
	ATOM	Increase Decrease In Unbilled Contracts Receivable IncreaseDecreaseInUnbilledContractsReceivable	-0	usd
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-14000	usd
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	42000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	335000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	232000	usd
	us-gaap	Increase Decrease In Other Accounts Payable IncreaseDecreaseInOtherAccountsPayable	-70000	usd
	us-gaap	Increase Decrease In Other Accounts Payable IncreaseDecreaseInOtherAccountsPayable	165000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	27000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	45000	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-788000	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-389000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-166000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-139000	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	13000	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	0	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7313000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-8172000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	6000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	18000	usd
	ATOM	Purchase Of Availableforsale Securities PurchaseOfAvailableforsaleSecurities	4290000	usd
	ATOM	Purchase Of Availableforsale Securities PurchaseOfAvailableforsaleSecurities	10853000	usd
	ATOM	Maturity Of Availableforsale Securities MaturityOfAvailableforsaleSecurities	7500000	usd
	ATOM	Maturity Of Availableforsale Securities MaturityOfAvailableforsaleSecurities	0	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	3204000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-10871000	usd
	ATOM	Proceeds From At The Market Sale Of Stock ProceedsFromAtTheMarketSaleOfStock	6392000	usd
	ATOM	Proceeds From At The Market Sale Of Stock ProceedsFromAtTheMarketSaleOfStock	11063000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	86000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	78000	usd
	ATOM	Proceeds From Issuance Or Sale Of Stock ProceedsFromIssuanceOrSaleOfStock	10000	usd
	ATOM	Proceeds From Issuance Or Sale Of Stock ProceedsFromIssuanceOrSaleOfStock	0	usd
	ATOM	Payments Of Principal For Financing Lease PaymentsOfPrincipalForFinancingLease	486000	usd
	ATOM	Payments Of Principal For Financing Lease PaymentsOfPrincipalForFinancingLease	378000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6002000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	10763000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	1893000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-8280000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12591000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	40000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	116000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	102000	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	562000	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	581000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2011000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1957000	usd
	ATOM	Unrealized Gain Loss On Cash Equivalents UnrealizedGainLossOnCashEquivalents	1000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	-87000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	-89000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	6000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-0	usd
	ATOM	Increase Decrease In Unbilled Contracts Receivable IncreaseDecreaseInUnbilledContractsReceivable	-550000	usd
	ATOM	Increase Decrease In Unbilled Contracts Receivable IncreaseDecreaseInUnbilledContractsReceivable	-0	usd
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-14000	usd
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	42000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	335000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	232000	usd
	us-gaap	Increase Decrease In Other Accounts Payable IncreaseDecreaseInOtherAccountsPayable	-70000	usd
	us-gaap	Increase Decrease In Other Accounts Payable IncreaseDecreaseInOtherAccountsPayable	165000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	27000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	45000	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-788000	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-389000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-166000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-139000	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	13000	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	0	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7313000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-8172000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	6000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	18000	usd
	ATOM	Purchase Of Availableforsale Securities PurchaseOfAvailableforsaleSecurities	4290000	usd
	ATOM	Purchase Of Availableforsale Securities PurchaseOfAvailableforsaleSecurities	10853000	usd
	ATOM	Maturity Of Availableforsale Securities MaturityOfAvailableforsaleSecurities	7500000	usd
	ATOM	Maturity Of Availableforsale Securities MaturityOfAvailableforsaleSecurities	0	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	3204000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-10871000	usd
	ATOM	Proceeds From At The Market Sale Of Stock ProceedsFromAtTheMarketSaleOfStock	6392000	usd
	ATOM	Proceeds From At The Market Sale Of Stock ProceedsFromAtTheMarketSaleOfStock	11063000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	86000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	78000	usd
	ATOM	Proceeds From Issuance Or Sale Of Stock ProceedsFromIssuanceOrSaleOfStock	10000	usd
	ATOM	Proceeds From Issuance Or Sale Of Stock ProceedsFromIssuanceOrSaleOfStock	0	usd
	ATOM	Payments Of Principal For Financing Lease PaymentsOfPrincipalForFinancingLease	486000	usd
	ATOM	Payments Of Principal For Financing Lease PaymentsOfPrincipalForFinancingLease	378000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6002000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	10763000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	1893000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-8280000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	21184000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14484000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12904000	usd
	us-gaap	Interest Paid Net InterestPaidNet	63000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	21184000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14484000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12904000	usd
	us-gaap	Interest Paid Net InterestPaidNet	63000	usd
	us-gaap	Interest Paid Net InterestPaidNet	104000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_804_eus-gaap--NatureOfOperations_zSuMaKL0ujIg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_82F_zKudWs13ENG4">NATURE OF OPERATIONS</span></b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Atomera Incorporated (“Atomera” or the “Company”) was incorporated in the state of Delaware in March 2007 under the name MEARS Technologies, Inc. and is engaged in the development, commercialization and licensing of proprietary processes and technologies for the semiconductor industry. On January 12, 2016, the Company changed its name to Atomera Incorporated.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Atomera is an early-stage company, having only limited revenue-generating activities, and is devoting substantially all its efforts toward technology research and development and to commercially licensing its technology to designers and manufacturers of integrated circuits.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p>
CY2024Q2	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	18300000	usd
CY2024Q2	ATOM	Working Capital WorkingCapital	15800000	usd
	us-gaap	Interest Paid Net InterestPaidNet	104000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_804_eus-gaap--NatureOfOperations_zSuMaKL0ujIg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_82F_zKudWs13ENG4">NATURE OF OPERATIONS</span></b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Atomera Incorporated (“Atomera” or the “Company”) was incorporated in the state of Delaware in March 2007 under the name MEARS Technologies, Inc. and is engaged in the development, commercialization and licensing of proprietary processes and technologies for the semiconductor industry. On January 12, 2016, the Company changed its name to Atomera Incorporated.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Atomera is an early-stage company, having only limited revenue-generating activities, and is devoting substantially all its efforts toward technology research and development and to commercially licensing its technology to designers and manufacturers of integrated circuits.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p>
CY2024Q2	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	18300000	usd
CY2024Q2	ATOM	Working Capital WorkingCapital	15800000	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	72000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	0	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	90000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	0	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	72000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	0	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	90000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	0	usd
CY2024Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	13000	usd
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4180000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3919000	shares
CY2023Q2	us-gaap	Lessee Operating Lease Description LesseeOperatingLeaseDescription	Effective May 1, 2023, the Company leased an additional 404 square feet at its Tempe office location under an amendment to its current lease. The monthly rent payment increased from $1,277 per month to $2,365 per month and the increased rent under the amended lease is accounted for as a modification to the lease under ASC 842 at the time of commencement.
CY2023	us-gaap	Lessee Operating Lease Description LesseeOperatingLeaseDescription	In December 2023, the Company entered into a lease agreement for a tool in Tempe, Arizona. The term of this lease is for 12 months beginning on January 1, 2024 for $87,000 per month. Since the lease term is not for more than one year and there are no extension provisions in the lease, the future lease payments are not included in the lease obligations on the Company’s condensed balance sheets.
	us-gaap	Lessee Operating Lease Option To Terminate LesseeOperatingLeaseOptionToTerminate	The Company terminated its office lease in Cambridge, Massachusetts as of March 31, 2023. The cost of the lease was $2,942 per month.
CY2024Q2	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	281000	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	72000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	0	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	90000	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	72000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	0	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	90000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	0	usd
CY2024Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	13000	usd
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4180000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3919000	shares
CY2023Q2	us-gaap	Lessee Operating Lease Description LesseeOperatingLeaseDescription	Effective May 1, 2023, the Company leased an additional 404 square feet at its Tempe office location under an amendment to its current lease. The monthly rent payment increased from $1,277 per month to $2,365 per month and the increased rent under the amended lease is accounted for as a modification to the lease under ASC 842 at the time of commencement.
CY2023	us-gaap	Lessee Operating Lease Description LesseeOperatingLeaseDescription	In December 2023, the Company entered into a lease agreement for a tool in Tempe, Arizona. The term of this lease is for 12 months beginning on January 1, 2024 for $87,000 per month. Since the lease term is not for more than one year and there are no extension provisions in the lease, the future lease payments are not included in the lease obligations on the Company’s condensed balance sheets.
	us-gaap	Lessee Operating Lease Option To Terminate LesseeOperatingLeaseOptionToTerminate	The Company terminated its office lease in Cambridge, Massachusetts as of March 31, 2023. The cost of the lease was $2,942 per month.
CY2024Q2	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	281000	usd
CY2023Q2	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	290000	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	562000	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	581000	usd
CY2024Q2	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	35000	usd
CY2023Q2	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	51000	usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	74000	usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	104000	usd
CY2024Q2	us-gaap	Lease Cost LeaseCost	316000	usd
CY2023Q2	us-gaap	Lease Cost LeaseCost	341000	usd
	us-gaap	Lease Cost LeaseCost	636000	usd
CY2023Q2	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	290000	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	562000	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	581000	usd
CY2023Q2	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	51000	usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	74000	usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	104000	usd
CY2024Q2	us-gaap	Lease Cost LeaseCost	316000	usd
CY2023Q2	us-gaap	Lease Cost LeaseCost	341000	usd
	us-gaap	Lease Cost LeaseCost	636000	usd
	us-gaap	Lease Cost LeaseCost	685000	usd
CY2024Q2	ATOM	Fixed Lease Costs FixedLeaseCosts	65000	usd
CY2023Q2	ATOM	Fixed Lease Costs FixedLeaseCosts	64000	usd
	ATOM	Fixed Lease Costs FixedLeaseCosts	131000	usd
	ATOM	Fixed Lease Costs FixedLeaseCosts	126000	usd
CY2024Q2	us-gaap	Short Term Lease Cost ShortTermLeaseCost	261000	usd
CY2023Q2	us-gaap	Short Term Lease Cost ShortTermLeaseCost	244000	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	522000	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	541000	usd
CY2024Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	326000	usd
CY2023Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	308000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	653000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	667000	usd
CY2024Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	61000	usd
CY2023Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	55000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	171000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	111000	usd
CY2024Q2	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	330000	usd
CY2023Q2	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	241000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	549000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	482000	usd
CY2024Q2	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2023Q2	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	33000	usd
CY2024Q2	ATOM	Fixed Lease Costs FixedLeaseCosts	65000	usd
CY2023Q2	ATOM	Fixed Lease Costs FixedLeaseCosts	64000	usd
	ATOM	Fixed Lease Costs FixedLeaseCosts	131000	usd
	ATOM	Fixed Lease Costs FixedLeaseCosts	126000	usd
CY2024Q2	us-gaap	Short Term Lease Cost ShortTermLeaseCost	261000	usd
CY2023Q2	us-gaap	Short Term Lease Cost ShortTermLeaseCost	244000	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	522000	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	541000	usd
CY2024Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	326000	usd
CY2023Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	308000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	653000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	667000	usd
CY2024Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	61000	usd
CY2023Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	55000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	171000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	111000	usd
CY2024Q2	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	330000	usd
CY2023Q2	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	241000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	549000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	482000	usd
CY2024Q2	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	33000	usd
CY2024Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0550	pure
CY2024Q2	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0525	pure
CY2024Q2	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y1M6D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	1400000	shares
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	33000	usd
CY2024Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0550	pure
CY2024Q2	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0525	pure
CY2024Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y8M12D
CY2024Q2	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y1M6D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	1400000	shares
CY2024Q2	us-gaap	Share Based Compensation ShareBasedCompensation	987000	usd
CY2023Q2	us-gaap	Share Based Compensation ShareBasedCompensation	1030000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2011000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1957000	usd
CY2024Q2	us-gaap	Share Based Compensation ShareBasedCompensation	987000	usd
CY2023Q2	us-gaap	Share Based Compensation ShareBasedCompensation	1030000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2011000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1957000	usd
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
atom-20240630_cal.xml	Edgar Link	unprocessable
atom-20240630_def.xml	Edgar Link	unprocessable
0001683168-24-005141-index-headers.html	Edgar Link	pending
0001683168-24-005141-index.html	Edgar Link	pending
0001683168-24-005141.txt	Edgar Link	pending
0001683168-24-005141-xbrl.zip	Edgar Link	pending
atom-20240630.xsd	Edgar Link	pending
atomera_ex3101.htm	Edgar Link	pending
atomera_ex3102.htm	Edgar Link	pending
atomera_ex3201.htm	Edgar Link	pending
atomera_i10q-063024.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
atom-20240630_lab.xml	Edgar Link	unprocessable
atom-20240630_def.xml	Edgar Link	unprocessable
atom-20240630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
atomera_i10q-063024_htm.xml	Edgar Link	completed
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
0001683168-24-005141-index-headers.html	Edgar Link	pending
0001683168-24-005141-index.html	Edgar Link	pending
0001683168-24-005141.txt	Edgar Link	pending
0001683168-24-005141-xbrl.zip	Edgar Link	pending
atom-20240630.xsd	Edgar Link	pending
atomera_ex3101.htm	Edgar Link	pending
atomera_ex3102.htm	Edgar Link	pending
atomera_ex3201.htm	Edgar Link	pending
atomera_i10q-063024.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
atom-20240630_lab.xml	Edgar Link	unprocessable
atom-20240630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
atomera_i10q-063024_htm.xml	Edgar Link	completed
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
atom-20240630_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ATOM
Atomera Inc Stock $atom

2024 Q3 Form 10-Q Financial Statement

#000168316824005141 Filed on July 30, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ATOM Atomera Inc Stock $atom

2024 Q3 Form 10-Q Financial Statement

#000168316824005141 Filed on July 30, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ATOM
Atomera Inc Stock $atom